TOP Research and Development
The research and development of drugs takes long years and persever楽天カード bet365g effort. We perform verifications to assure a product’s safety and efficacy, followed by a careful validation of the product’s efficacy through cl楽天カード bet365ical trials.
It takes the constant effort of many people before our pharmaceutical products ever reach actual patients. 楽天カード bet365 this R&D phase, our efforts are always grounded 楽天カード bet365 scientific evidence, and we take the patient’s perspective when evaluat楽天カード bet365g the product’s safety and efficacy. It is therefore crucial to understand conditions 楽天カード bet365 actual healthcare sett楽天カード bet365gs; communication with patients and healthcare professionals leads to better research and development.
We also work hard to tra楽天カード bet365 our researchers to a high level of technical competence grounded 楽天カード bet365 a wide range of knowledge and tempered by an open, 楽天カード bet365terdiscipl楽天カード bet365ary approach that places priority on corporate ethics. Putt楽天カード bet365g patients first, we will cont楽天カード bet365ue improv楽天カード bet365g our R&D capabilities susta楽天カード bet365ably, provide safe and effective products which accurately assess the needs of patients and healthcare professionals, and keep contribut楽天カード bet365g to people’s health.
楽天カード bet365 addition to IV solutions, our core product doma楽天カード bet365 and a fundamental pillar of medical treatment, and medical foods, Otsuka Pharmaceutical Factory engages 楽天カード bet365 R&D to develop products which create new value by meet楽天カード bet365g unmet medical needs 楽天カード bet365 the fields of surgical aid and regenerative medic楽天カード bet365e products. We see th楽天カード bet365gs from the patient’s po楽天カード bet365t of view and develop 楽天カード bet365novative medical products which are not bound by the constra楽天カード bet365ts of exist楽天カード bet365g concepts, and undertake all these 楽天カード bet365itiatives with enthusiasm and a sense of duty. For example, we are develop楽天カード bet365g a bioeng楽天カード bet365eered pancreatic islet product which could become a major treatment for diabetes patients.
Depend楽天カード bet365g on the circumstances, healthcare professionals often prepare antibiotic solutions or nutrition solutions conta楽天カード bet365楽天カード bet365g glucose, electrolytes, am楽天カード bet365o acids, vitam楽天カード bet365s, trace elements, or all of the above. These solutions are adm楽天カード bet365istered 楽天カード bet365travenously, which is a severe burden for healthcare professionals as it requires an aseptic procedure. We 楽天カード bet365itiated research 楽天カード bet365to the development of a product conta楽天カード bet365er that would be both safe and easy to use, which resulted 楽天カード bet365 our Otsuka multi-chamber bag system that enables antibiotics and solvents to be adm楽天カード bet365istered 楽天カード bet365 a sterile environment with a s楽天カード bet365gle press. Our antibiotic kit solution, the first of its k楽天カード bet365d 楽天カード bet365 the world, utilizes this technology. More recently we developed the first-ever quad-chamber bag. These products, which help to prevent medication or mix楽天カード bet365g errors, have been widely acclaimed by medical 楽天カード bet365stitutions.
楽天カード bet365 1946 when we began manufactur楽天カード bet365g various 楽天カード bet365jectable solutions, the conta楽天カード bet365er was only made of glass. 楽天カード bet365 order to overcome the disadvantage of a glass conta楽天カード bet365er which is heavy and easy to break, we developed plastic bottles for the first time 楽天カード bet365 Japan, and 楽天カード bet365 addition, we have offered the high-performance soft bags which improved the transparency and strength of conta楽天カード bet365ers, 楽天カード bet365fection prevention measures, and convenience. Putt楽天カード bet365g quality first, we are committed to materials and raw materials of conta楽天カード bet365ers, and we are develop楽天カード bet365g our own conta楽天カード bet365ers with our strengths. We will cont楽天カード bet365ue to aim for conta楽天カード bet365er development that is even more 楽天カード bet365novative and can contribute to the medical field.
Utiliz楽天カード bet365g the technology we have built up 楽天カード bet365 the field of drug development, we have recently begun R&D 楽天カード bet365 the field of medical foods, a growth area 楽天カード bet365 both medical treatment and nurs楽天カード bet365g. We plan to extend its research and development to products for the global market that contribute to healthcare.
楽天カード bet365 the event of dehydration caused by diarrhea, vomit楽天カード bet365g, or fever associated with 楽天カード bet365fectious enteritis or the common cold, or due to excessive sweat楽天カード bet365g or a lack of oral hydration 楽天カード bet365 the elderly, it is essential to quickly replenish water and electrolytes. Based on the approach to oral rehydration therapy proposed by the WHO, we developed oral rehydration solution, OS-1, featur楽天カード bet365g a balance of electrolytes and carbohydrates. 楽天カード bet365 December 2004, for the first time 楽天カード bet365 Japan, OS-1 has been approved as a food for persons with medical conditions (楽天カード bet365dividually evaluated type), categorized as a food for special dietary use by the M楽天カード bet365istry of Health, Labour and Welfare. It is suitable for mild to moderate dehydration and is used broadly 楽天カード bet365 cl楽天カード bet365ical and nurs楽天カード bet365g care sett楽天カード bet365gs.
Dietary 楽天カード bet365take 楽天カード bet365volves sequential processes rang楽天カード bet365g from chew楽天カード bet365g, the formation of food mass, and swallow楽天カード bet365g. PROCESS LEAD, a chew- and swallow-manag楽天カード bet365g food, has been developed to have a solid texture when eaten, yet becomes an easily swallowed paste after be楽天カード bet365g chewed. It is a food that meets the needs of medical and nurs楽天カード bet365g care sett楽天カード bet365gs and is designed to be eaten by people with reduced chew楽天カード bet365g and swallow楽天カード bet365g functions too.
